
GuiZhou SanLi Pharmaceutical Co.,Ltd
SSE:603439.SS
Overview | Financials
Company Name | GuiZhou SanLi Pharmaceutical Co.,Ltd |
Symbol | 603439.SS |
Currency | CNY |
Price | 12.16 |
Market Cap | 4,887,501,632 |
Dividend Yield | 0.62% |
52-week-range | 10.69 - 16.5 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Hai Zhang |
Website | https://www.gz-sanli.com |
An error occurred while fetching data.
About GuiZhou SanLi Pharmaceutical Co.,Ltd
GuiZhou SanLi Pharmaceutical Co.,LTD. engages in the research and development, production, and marketing of pharmaceutical products. It offers pediatric medication, respiratory system medication, cardiovascular and cerebrovascular drugs, digestive medicine, trauma injury medication, rehabilitation medicine, and ophthalmic medicine. The company was founded in 1995 and is based in Guiyang, China.
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD